ORGO logo

ORGO
Organogenesis Holdings Inc - Ordinary Shares - Class A

3,241
Mkt Cap
$342.27M
Volume
259,108.00
52W High
$7.08
52W Low
$2.04
PE Ratio
-16.73
ORGO Fundamentals
Price
$2.58
Prev Close
$2.66
Open
$2.60
50D MA
$2.44
Beta
1.96
Avg. Volume
2.29M
EPS (Annual)
$0.1537
P/B
1.40
Rev/Employee
$660,619.44
$796.28
Loading...
Loading...
News
all
press releases
Organogenesis (ORGO) Projected to Post Earnings on Thursday
Organogenesis (NASDAQ:ORGO) will be releasing its Q1 2026 earnings after the market closes on Thursday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-7-organogenesis-holdings-inc-stock...
News Placeholder
More News
News Placeholder
Organogenesis (NASDAQ:ORGO) Trading Up 1.7% - Time to Buy?
Organogenesis (NASDAQ:ORGO) Shares Up 1.7% - What's Next...
News Placeholder
ORGO Stock Rallies After Hours On Clearing Regulatory Pathway For Pain Relief Treatment
Organogenesis is seeking approval for ReNu in knee osteoarthritis pain, a degenerative joint disease that is estimated to affect nearly 31.1 million Americans.
News Placeholder
Organogenesis (NASDAQ:ORGO) Receives "Buy" Rating from BTIG Research
BTIG Research reissued a "buy" rating and issued a $8.00 price objective on shares of Organogenesis in a research report on Thursday...
News Placeholder
Assenagon Asset Management S.A. Acquires 680,392 Shares of Organogenesis $ORGO
Assenagon Asset Management S.A. raised its stake in shares of Organogenesis (NASDAQ:ORGO - Free Report) by 14.0% during the fourth quarter, according to its most recent disclosure with the Securities...
News Placeholder
Organogenesis $ORGO Shares Acquired by First Light Asset Management LLC
First Light Asset Management LLC lifted its stake in shares of Organogenesis (NASDAQ:ORGO - Free Report) by 10.6% during the 3rd quarter, according to the company in its most recent filing with the...
News Placeholder
Insider Buying: Organogenesis (NASDAQ:ORGO) Director Buys 5,000 Shares of Stock
Organogenesis (NASDAQ:ORGO - Get Free Report) Director Arthur Leibowitz purchased 5,000 shares of the stock in a transaction on Monday, March 9th. The stock was acquired at an average cost of $2.68...
News Placeholder
Michael Joseph Driscoll Buys 10,000 Shares of Organogenesis (NASDAQ:ORGO) Stock
Organogenesis (NASDAQ:ORGO - Get Free Report) Director Michael Joseph Driscoll purchased 10,000 shares of the business's stock in a transaction on Monday, March 9th. The shares were purchased at an...
News Placeholder
Insider Buying: Organogenesis (NASDAQ:ORGO) Director Buys $13,400.00 in Stock
Organogenesis (NASDAQ:ORGO - Get Free Report) Director Arthur Leibowitz acquired 5,000 shares of the firm's stock in a transaction on Monday, March 9th. The shares were acquired at an average price...
News Placeholder
Organogenesis (NASDAQ:ORGO) Director Michael Joseph Driscoll Purchases 10,000 Shares of Stock
Organogenesis (NASDAQ:ORGO - Get Free Report) Director Michael Joseph Driscoll bought 10,000 shares of the firm's stock in a transaction dated Monday, March 9th. The stock was purchased at an average...
<
1
2
...
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available